Developing new methods for creating cancer-fighting drugs
Official title: New Catalysts and Strategies for Selective C–H Functionalization and Cycloaddition Reactions
Funded at University of Virginia · NIH-10904658 · Data updated 2026-11-12
This study is exploring new ways to create small molecules that could become better cancer treatments, making it easier to find effective medications for patients who need them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project start | September 1, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $387,915 |
| NIH project number | 5R35GM149212-02 |
| Project ID | NIH-10904658 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with cancer or those at risk of developing cancer who may benefit from new therapeutic options.
✕Less likely to help
Patients with conditions unrelated to cancer or those who are not seeking new treatment options may not benefit from this research.
What this research studies
This research focuses on improving the processes used to create small molecules that can be developed into new drugs, particularly for cancer treatment. The team is working on innovative methods to selectively modify chemical compounds, which can lead to more effective therapies. By overcoming current limitations in organic synthesis, they aim to accelerate the discovery of new medications that address unmet medical needs. The research involves collaboration with other projects to apply these new compounds to target biological processes relevant to cancer.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective cancer treatments through improved drug synthesis methods.
How similar studies have gone: Other research in the field of organic synthesis and drug discovery has shown promise, indicating that this approach could lead to significant advancements in cancer treatment.
Where this research is happening
-
University of Virginia
Charlottesville, United States Active
Researchers
- Principal investigator: Hilinski, Michael Kenneth — University of Virginia
- Study coordinator: Hilinski, Michael Kenneth
Related research
Other NIH-funded projects on the same topics.
-
STeroids and enhanced Antibiotics for sepsis in Africa with HIV/TB (STARS)
This grant tests whether adding steroids and stronger antibiotics helps adults with severe sepsis tied to HIV/TB in areas with high TB rates.
-
Steroids and better antibiotics for sepsis in people with AIDS in Africa
This study tests whether adding hydrocortisone and stronger antibiotics can improve survival for adults with sepsis who also have AIDS or advanced immune suppression in regions with high TB.
-
Predictive tools to improve pediatric donor heart use
A pediatric heart transplant grant is building data-driven tools to help doctors choose the best donor hearts for children.
-
Microglia Help Finish Seizures and Heal the Brain
Scientists are studying how brain immune cells (microglia) help end severe seizures and repair brain damage, with potential new ideas for people who have had status epilepticus.
-
Small molecules that boost the 20S proteasome to fight Alzheimer’s and related dementias
A new approach tests small molecules that activate the 20S proteasome to help neurons clear harmful proteins and slow the spread of disease in people affected by Alzheimer's and related dementias.
-
Advanced genome and transcriptome analysis with long-read sequencing
A researcher at a university is using long-read DNA and RNA sequencing to map complete genomes and transcriptomes for individuals to understand how genetic variations relate to disease risk.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.